Healthcare
Amplifon S.p.A.(AMFPF)
Live Price
Offline$12.01
+0.00% today
1Y Change
-53.00%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $2.09B
- Revenue Growth
- -0.6%
- EPS Growth
- -37.5%
- Dividend Yield
- 3.0%
Coverage: 257 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Amplifon S.p.A. (AMFPF) is a Healthcare stock with a market cap of $2.09B and listed on OTC. The stock last traded around $12.01 and down 53.0% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of -0.6%, EPS growth of -37.5%, a dividend yield of 3.0%. What stands out right now is revenue -0.6%, EPS -37.5%, free cash flow -100.0% with operating margin 8.5% and ROIC 5.0%. The dividend matters to the case here, with a current yield around 3.0%. Valuation is more restrained than many high-expectation growth names at P/E 23.6 and price/sales 0.9. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines AMFPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-0.6% vs +7.6% peer median
Operating Margin
Below sector median
+8.5% vs +19.4% peer median
P/E
Below sector median
23.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -0.6% and EPS is at -37.5%, with operating margin around 8.5%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 3.0%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.9% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | +0.0% | +5.8% | +0.8% |
2026 Mar 4, 2026 | +1.0% | +0.0% | +0.0% | -28.4% |
2025 Nov 6, 2025 | -0.9% | +0.0% | +0.0% | -13.6% |
Benchmark Edge
AMFPF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
AMFPF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
AMFPF Max Drawdown
-60.34%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for AMFPF and SPY.
Company Overview
Amplifon S.p.A.
Other OTC
Amplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound. The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices. It also provides fitting of customized products. As of March 18, 2022, the company operated a network of approximately 9,200 points of sale in 25 countries and 5 continents. The company also sells its products through 1,350 franchisees. It has operations in Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company was founded in 1950 and is headquartered in Milan, Italy.
- Leadership
- Enrico Vita
- IPO Date
- Nov 11, 2003
- Employees
- 11.6k
- Street Address
- Via Ripamonti 133
- Mailing
- Milan, MI, 20141
- Region
- Milan, MI, IT
- Reporting Currency
- USD
- Investor Line
- +39 02 5747 21
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 23.6
- EV/EBITDA
- 6.5
- Price/Sales
- 0.9
- Price/Book
- 2.2
Growth
- Revenue
- -0.6%
- EPS
- -37.5%
- Free Cash Flow
- -100.0%
Profitability
- Gross Margin
- 15.0%
- Operating Margin
- 8.5%
- Net Margin
- 3.8%
- ROE
- 8.9%
- ROIC
- 5.0%
Balance Sheet
- Debt/Equity
- 1.53
- Current Ratio
- 0.52
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.